Skip to Content

Cronos Group Inc CRON Stock Quote

| Rating as of

Morningstar‘s Stock Analysis CRON

Currency in CAD
Is it the right time to buy or sell?
Is it the right time to buy or sell?

1-Star Price


5-Star Price


Economic Moat


Capital Allocation


Cronos Continues to Face Challenging Canadian Market but Has the Cash to Outlast Consolidation

Business Strategy and Outlook

| Kristoffer Inton |

Cronos Group cultivates and sells cannabis predominantly in Canada and hemp-derived CBD in the U.S. but also participates in the global medical cannabis market.

Unlock Our Full Analysis With Morningstar Investor

Key Statistics CRON

Company Profile CRON

Business Description

Cronos Group, headquartered in Toronto, Canada cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis to Poland and Germany. In addition, it has entered joint ventures in Israel, Colombia, and Australia to drive further international cultivation and distribution growth. In the U.S. the company directly sells hemp-derived CBD and has an option to acquire 10.5% of U.S. multistate operator PharmaCann.

111 Peter Street, Suite 300
Toronto, ON, M5V2G9, Canada
T +1 416 504-0004
Industry Drug Manufacturers - Specialty & Generic
Most Recent Earnings Jun 30, 2022
Fiscal Year End Dec 31, 2022
Employees 626